AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

CLEARVUE TECHNOLOGIES LIMITED Capital/Financing Update 2021

Sep 26, 2021

64697_rns_2021-09-26_98ca4798-2cf9-44c9-a1b1-12bbfc0383de.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

ASX Announcement – 24 September 2021

ASX Release ǀ ClearVue Technologies Limited (ASX: CPV)

Notice Under Section 708A(5)(e) of the Corporations Act

On 23 September 2021, ClearVue Technologies Limited (ASX:CPV) ( ClearVue or the Company ) issued a total of 50,000 fully paid ordinary shares on exercise of 50,000 unlisted options over shares, each option exercisable at $0.20, expiring on 31 December 2022. The issue of shares was under an exception to the Company’s Listing Rule 7.1 capacity.

The Company has also issued 16,479 fully paid ordinary shares to consultant services equivalent to $7,500. The equivalent price per share is $0.4551, being the Company’s 15 day trading VWAP to 30 June 2021 (inclusive). The issue of shares was under the Company’s Listing Rule 7.1 capacity.

The shares issued under this announcement have been without disclosure to investors under section 708A(5) of the Corporations Act 2001 (Cth) ( Corporations Act ).

For the purposes of section 708A(6) of the Corporations Act, the Company gives notice under section 708A(5)(e) of the Corporations Act as follows:

a) the Company issued the Shares without disclosure to investors under Part 6D.2 of the Corporations Act;
b) as at the date of this notice the Company has complied with:
- i) the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and ii) section 674 of the Corporations Act; and
c) as at the date of this notice, there is no excluded information of the type referred to in sections 708A(7) and 708A(8) of the Corporations Act.

This announcement is authorised for release by the Board of ClearVue Technologies Limited.

For further information, please contact: